Allergies News and Research

Latest Allergies News and Research

Recent progress in TB diagnostics and prevention approaches offers hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.

11 Feb 2020

Young sexual minority men do not fully understand their risk for HPV infection

Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus due to a lack of information from health care providers, according to Rutgers researchers.

11 Feb 2020

Study to evaluate safety of PrEP and dapivirine ring in pregnant women

A woman who is eight-months pregnant is the first participant to be enrolled into a study evaluating the safety and acceptability of two different HIV prevention approaches when used during pregnancy -- the monthly dapivirine vaginal ring, which is currently under regulatory review, and a daily antiretroviral (ARV) pill called Truvada, an approach already approved in several countries and commonly referred to as PrEP, short for pre-exposure prophylaxis.

10 Feb 2020

New clinical trial to examine the safety of dapivirine vaginal ring and PrEP in pregnant women

The first clinical trial specifically designed to test the safety of the monthly dapivirine vaginal ring in pregnant women has begun in southern and eastern Africa.

10 Feb 2020

New treatment approach for eosinophilic chronic rhinosinusitis

Eosinophilic chronic rhinosinusitis is a type of airway disease involving nasal inflammation. Many studies have attempted to understand the molecular-based pathogenesis of recurrent ECRS; none have provided a clear explanation, until now.

6 Feb 2020

Study may suggest new therapeutic approaches to control immune responses

Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

5 Feb 2020

Promising HIV vaccine fails in a large-scale clinical trial

The human immune deficiency virus (HIV) is an infectious disease that can lead to immunosuppression called acquired immunodeficiency syndrome (AIDS). For decades, scientists race to discover a vaccine that can help prevent the spread of the virus. The latest trial testing a new experimental vaccine in South Africa end in disappointment after deeming ineffective in preventing infection.

4 Feb 2020

FDA-approved OIT product marks major milestone in management of peanut allergies

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through desensitization over time.

4 Feb 2020

UH professor examines life cycle of drug-resistant persister cells in recurrent infections

A University of Houston engineering professor is examining the life cycle of stubborn, drug-resistant persister cells in recurrent infections to find a way to destroy them.

4 Feb 2020

Investigational HIV vaccine not effective in preventing HIV

The National Institute of Allergy and Infectious Diseases), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine.

3 Feb 2020

Coronavirus taking an economic toll on China

The novel coronavirus or 2019-nCoV outbreak has negatively impacted the economy of China and other countries worldwide. With China’s isolation from other countries and travel bans imposed, the economic toll is rippling across the world.

3 Feb 2020

No masking the best way to avoid the scary coronavirus: Wash your hands

Americans are watching with alarm as a new coronavirus spreads in China and cases pop up in the United States. They are barraged with information about what kinds of masks are best to prevent viral spread. Students are handing out masks in Seattle. Masks have run out in Brazos County, Texas.

31 Jan 2020

State-purchased insurance plans improve HIV outcomes, save healthcare costs

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.

30 Jan 2020

Conceived through ‘fertility fraud,’ she now needs fertility treatment

When Heather Woock was in her late 20s, she started researching her family history. As part of the project, she spit into a tube and sent it to Ancestry, a consumer DNA testing service. Then, in 2017, she started getting messages about the results from people who said they could be half siblings.

28 Jan 2020

Clinical trial to test safety, effectiveness of mAb against malaria in healthy volunteers

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.

27 Jan 2020

Early life exposure to traffic-related air pollution may cause structural brain changes at age 12

A new study suggests that significant early childhood exposure to traffic-related air pollution (TRAP) is associated with structural changes in the brain at the age of 12.

24 Jan 2020

NIAID officials describe steps to control coronavirus that recently originated in China

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak.

24 Jan 2020

Long-term air pollution makes rhinitis symptoms worse

A new study published in the Journal of Allergy and Clinical Immunology reports that people exposed to polluted air out of doors show more severe symptoms of rhinitis, a very common condition also called a cold. This is due to an inflammation of the nasal mucosa.

23 Jan 2020

Being exposed to diesel exhaust particles raises pneumococcal disease risk

Air pollution is a long-standing global problem, which is responsible for 7 million deaths each year, with 7 percent of these attributed to pneumonia. A new study highlights how air pollution affects the airways making the body susceptible to developing the pneumococcal disease.

23 Jan 2020

Study sheds light on mechanisms that underlie a rare genetic condition

A team of researchers at CHU Sainte-Justine and Université de Montréal has shed light on the mechanisms that underlie a rare genetic condition by creating the first cellular model of the disease.

22 Jan 2020